Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis
Status:
Recruiting
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
Radiation induced oral mucositis which may result in reduced quality of life is commonly seen
during radiotherapy, especially combined with chemotherapy. This study is a prospective,
multicenter, and exploratory study. The aim of this study is to explore predictive factors of
acute radiotherapy induced oral mucositis in nasopharyngeal carcinoma patients treated with
radio-chemotherapy and reduce incidence of oral mucositis by using recombinant human
interleukin -11.